The (new) top 10 pharma companies by 2017 revenue

Takeda CEO Christophe Weber will now be able to boast about his elevation into the top 10 global pharma companies, if you base the count on revenue. 

I cobbled together the latest set of figures for fiscal 2017 to show you where the Takeda/Shire operation fits in to the big picture. I’ll note that while J&J is way out front, it’s a healthcare/pharma conglomerate with a wide range of products in its portfolio. And I backed out crop sciences revenue from Bayer to make this more about biopharma.

Finally, I added Gilead as number 11 to provide some added context on Takeda/Shire.

The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 37,600+ biopharma pros who read Endpoints News by email every day.

Free Subscription

Biotech Investment Analyst
SV Health Investors Boston, MA
Director, Program Management
Contrafect Corporation New York, NY
Director, Translational Sciences
Cadent Therapeutics Cambridge, MA

Visit Endpoints Careers ->